News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

San Diego's Auspex Pharmaceuticals Sets Terms For $61 Million IPO



1/17/2014 9:38:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Auspex Pharmaceuticals, a clinical-stage biotech developing treatments for orphan diseases, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $61 million by offering 5.5 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Auspex Pharmaceuticals would command a market value of $231 million. Auspex Pharmaceuticals, which was founded in 2001, plans to list on the NASDAQ under the symbol ASPX.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES